Article ID Journal Published Year Pages File Type
9261570 Autoimmunity Reviews 2005 6 Pages PDF
Abstract
We have introduced substantial modifications in SEREX, designed to minimize confounding effects of unrelated autoantibodies and to eliminate steps that preclude the identification of cancer-related autoantigens commonly recognized by cancer sera. In addition, we incorporate methodology to identify candidate antigens that have potential diagnostic or prognostic value prior to their molecular cloning and characterization.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , ,